Immunic Therapeutics And Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory And Autoimmune Diseases; Vital Therapies Trading To Commence On Nasdaq Capital Market Under Symbol 'IMUX' On April 15